Production (Stage)
Coeptis Therapeutics Holdings, Inc.
COEP
$8.23
-$0.13-1.56%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.06M | -1.95M | -1.83M | -3.04M | -3.00M |
| Total Depreciation and Amortization | 305.30K | 260.00K | 278.20K | 250.20K | 259.30K |
| Total Amortization of Deferred Charges | 99.90K | 66.20K | 0.00 | 0.00 | 150.00K |
| Total Other Non-Cash Items | 507.10K | 229.50K | -203.10K | 1.40M | 611.90K |
| Change in Net Operating Assets | -220.80K | -44.30K | -138.80K | -29.00K | 77.70K |
| Cash from Operations | -2.37M | -1.44M | -1.89M | -1.42M | -1.90M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00K | 0.00 | 0.00 | -100.00K |
| Cash from Investing | -- | 100.00K | 0.00 | 0.00 | -100.00K |
| Total Debt Issued | 990.00K | 0.00 | 0.00 | 500.00K | 1.35M |
| Total Debt Repaid | -218.80K | -63.50K | 0.00 | -300.00K | -287.50K |
| Issuance of Common Stock | -- | 100.00K | -- | -- | 500.00K |
| Repurchase of Common Stock | -- | -- | -50.00K | -450.00K | -- |
| Issuance of Preferred Stock | 5.33M | 695.40K | 1.53M | 1.69M | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 400.00 | 0.00 | 0.00 | 500.00K | -- |
| Cash from Financing | 6.10M | 732.00K | 1.48M | 1.94M | 1.56M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 0.00 | 0.00 | -- | -- |
| Net Change in Cash | 3.74M | -604.60K | -417.60K | 525.80K | -439.90K |